ClariVest Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-33,600
Closed -$298K 877
2020
Q2
$298K Buy
+33,600
New +$290K 0.01% 484
2016
Q4
Sell
-67,800
Closed -$1.11M 744
2016
Q3
$1.11M Buy
67,800
+1,000
+1% +$14.1K 0.03% 291
2016
Q2
$637K Sell
66,800
-12,200
-15% -$133K 0.02% 338
2016
Q1
$1.11M Buy
79,000
+9,300
+13% +$96.2K 0.03% 272
2015
Q4
$757K Buy
69,700
+12,300
+21% +$111K 0.02% 316
2015
Q3
$391K Buy
57,400
+400
+0.7% +$3.1K 0.01% 344
2015
Q2
$520K Buy
+57,000
New +$432K 0.02% 329

Other funds holding NPTN

ClariVest Asset Management's NPTN Position: Q3 2020 in Review

ClariVest Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 33,600 shares — an estimated $298K sold.

ClariVest Asset Management first reported a position in NPTN in Q2 2015 and held it in 7 quarters. The position peaked at $1.11M in Q1 2016. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

  • ClariVest Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
  • ClariVest Asset Management sold 33,600 NEOPHOTONICS CORP shares in Q3 2020, an estimated $298K.
  • ClariVest Asset Management first reported a position in NEOPHOTONICS CORP in Q2 2015 and held it in 7 quarters.
  • ClariVest Asset Management's NEOPHOTONICS CORP position peaked at $1.11M in Q1 2016.
  • 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on ClariVest Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.